Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Ardian Symplicity Catheter · 1 trial · 1 indication
| Arm | Type | Description |
|---|---|---|
| Denervation | EXPERIMENTAL | Renal denervation using the Symplicty Catheter |
| Name | Type | Description |
|---|---|---|
| Ardian Symplicity™ Catheter | DEVICE | Renal denervation using the Symplicity Catheter |
Inclusion Criteria: * \>= 18 years of age. * a systolic blood pressure of 160 mmHg or greater. * receiving and adhering to full doses of an appropriate antihypertensive drug regimen for a minimum of two weeks prior to screening. * agrees to have the study procedure(s) performed and additional proce...
Ardian Symplicity Catheter is an investigational device being studied for the treatment of hypertension, specifically in patients with refractory hypertension. It is a catheter-based approach being evaluated in clinical research for its potential role in managing high blood pressure that does not respond adequately to standard therapies.
Ardian Symplicity Catheter is being developed by Medtronic plc, a medical technology company publicly traded under the ticker symbol MDT on the New York Stock Exchange. The company is conducting clinical research to evaluate the device's safety and effectiveness in treating hypertension.
Ardian Symplicity Catheter is in Phase 1 clinical development. It is an investigational device and has not been approved by regulatory authorities. The device is currently being studied in early-stage clinical trials to assess its safety and potential efficacy in patients with refractory hypertension.
Ardian Symplicity Catheter has been studied in one completed clinical trial with the identifier NCT00483808, titled 'Renal Denervation in Patients With Refractory Hypertension.' This Phase 1 study enrolled 73 participants with hypertension at sites in Australia and Poland. The trial has been completed, and no active trials are currently listed.
Ardian Symplicity Catheter is a device used in a procedure called renal denervation, which is the therapeutic approach being investigated in the clinical trial NCT00483808. The catheter is the tool used to perform the denervation procedure, which aims to treat refractory hypertension by modulating renal nerve activity.